Ulrich Fässler

Ulrich Fässler is the CEO and Chairman of SHL Medical, a Swiss company specializing in the production of autoinjectors for medications, including weight-loss treatments. Under his leadership, SHL Medical has experienced significant growth, particularly due to the rising demand for obesity medications in the United States. Fässler emphasizes the importance of these medications as preventative measures against serious health issues like cardiovascular diseases, advocating for better insurance coverage for patients.